K. Passoja et al., CLONING AND CHARACTERIZATION OF A 3RD HUMAN LYSYL HYDROXYLASE ISOFORM, Proceedings of the National Academy of Sciences of the United Statesof America, 95(18), 1998, pp. 10482-10486
Lysyl hydroxylase (EC 1.14.11.4), a ho modimer, catalyzes the formatio
n of hydroxylysine in collagens. Recently, an isoenzyme termed lysyl h
ydroxylase 2 has been cloned from human sources [M. Valtavaara, H. Pap
ponen, A.-M. Pirttila, K. Hiltunen, H. Helander and R. Myllyla (1997)
J. Biol. Chem. 272, 6831-6834]. We report here on the cloning of a thi
rd human lysyl hydroxylase isoenzyme, termed lysyl hydroxylase 3. The
cDNA clones encode a 738 amino acid polypeptide, including a signal pe
ptide of 24 residues. The overall amino acid sequence identity between
the processed human lysyl hydroxylase 3 and 1 polypeptides is 59%, an
d that between the processed lysyl hydroxylase 3 and 2 polypeptides is
57%, whereas the identity to the processed Caenorhabditis elegans pol
ypeptide is only 45%. All four recently identified critical residues a
t the catalytic site, two histidines, one aspartate, and one arginine,
are conserved in all these polypeptides. The mRNA for lysyl hydroxyla
se 3 was found to be expressed in a variety of tissues, but distinct d
ifferences appear to exist in the expression patterns of the three iso
enzyme mRNAs. Recombinant lysyl hydroxylase 3 expressed in insect cell
s by means of a baculovirus vector was found to be more soluble than l
ysyl hydroxylase 1 expressed in the same cell type. No differences in
catalytic properties were found between the recombinant lysyl hydroxyl
ase 3 and 1 isoenzymes. Deficiency in lysyl hydroxylase 1 activity is
known to cause the type M variant of the Ehlers-Danlos syndrome, and i
t is therefore possible that deficiency in lysyl hydroxylase 3 activit
y may lead to some other variant of this syndrome or to some other her
itable connective tissue disorder.